Minerva Neurosciences (NERV) Depreciation & Amortization (CF) (2014 - 2025)

Minerva Neurosciences has reported Depreciation & Amortization (CF) for 10 years, with the latest figure at $1360.0 in Q4 2025.

• For the quarter ending Q4 2025, Depreciation & Amortization (CF) changed 0.0% year-over-year to $1360.0; the trailing twelve-month figure through Mar 2026 stood at $4081.0 (down 25.02% YoY), and the FY2025 full-year result was $5442.0, changed 0.0% from the prior year.
• Depreciation & Amortization (CF) for Q4 2025 stood at $1360.0, roughly flat from $1361.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1361.0 in Q2 2023, with the low at $1360.0 in Q1 2023.
• Historically, Depreciation & Amortization (CF) has averaged $1360.5 across 3 years, with a median of $1360.5 in 2023.
• The largest YoY upside for Depreciation & Amortization (CF) was 0.07% in 2024 against a maximum downside of 0.07% in 2024.
• Minerva Neurosciences' Depreciation & Amortization (CF) stood at $1361.0 in 2023, then decreased by 0.07% to $1360.0 in 2024, then changed by 0.0% to $1360.0 in 2025.
• The last three Depreciation & Amortization (CF) figures came in at $1360.0 (Q4 2025), $1361.0 (Q3 2025), and $1360.0 (Q2 2025), per Business Quant data.